LCM
SWTX

Laurion Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Laurion Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-263,340
Closed -$9.92M – 571
2024
Q2 		$9.92M Sell
263,340
-108,734
-29% -$4.58M 0.12% 111
2024
Q1 		$18.3M Hold
372,074
– – 0.16% 126
2023
Q4 		$13.6M Buy
372,074
+479
+0.1% +$12.5K 0.12% 162
2023
Q3 		$8.59M Sell
371,595
-7,469
-2% -$204K 0.05% 230
2023
Q2 		$9.94M Sell
379,064
-18,632
-5% -$490K 0.06% 216
2023
Q1 		$10.2M Buy
397,696
+1,030
+0.3% +$30.1K 0.07% 194
2022
Q4 		$10.3M Hold
396,666
– – 0.05% 224
2022
Q3 		$11.3M Buy
396,666
+21,703
+6% +$622K 0.07% 181
2022
Q2 		$9.23M Buy
374,963
+207,579
+124% +$7.59M 0.14% 111
2022
Q1 		$9.45M Sell
167,384
-17,877
-10% -$1.02M 0.12% 120
2021
Q4 		$11.5M Hold
185,261
– – 0.12% 118
2021
Q3 		$11.8M Buy
185,261
+585
+0.3% +$45.1K 0.05% 251
2021
Q2 		$15.2M Sell
184,676
-33,590
-15% -$2.55M 0.08% 170
2021
Q1 		$16.1M Buy
218,266
+29,586
+16% +$2.32M 0.09% 191
2020
Q4 		$13.7M Buy
188,680
+25,000
+15% +$1.61M 0.11% 161
2020
Q3 		$7.8M Hold
163,680
– – 0.09% 182
2020
Q2 		$6.87M Hold
163,680
– – 0.08% 197
2020
Q1 		$4.42M Hold
163,680
– – 0.05% 259
2019
Q4 		$6.3M Sell
163,680
-144,300
-47% -$3.38M 0.05% 277
2019
Q3 		$6.68M Buy
+307,980
New +$7.28M 0.05% 292

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Laurion Capital Management's SWTX Position: Q3 2024 in Review

Laurion Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2024, closing a stake of 263,340 shares — an estimated $9.92M sold.

Laurion Capital Management first reported a position in SWTX in Q3 2019 and held it in 20 quarters. The position peaked at $18.3M in Q1 2024. 226 funds tracked by Wall St. Rank hold SWTX as of Q3 2024.

  • Laurion Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 263,340 SpringWorks Therapeutics shares in Q3 2024, an estimated $9.92M.
  • Laurion Capital Management first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 20 quarters.
  • Laurion Capital Management's SpringWorks Therapeutics position peaked at $18.3M in Q1 2024.
  • 226 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.